Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith the presentation made to the Investors/ Analysts at the Investor/ Analyst Call held today i.e. 16th May 2024.16-05-2024
16-05-2024
Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 68th Annual General Meeting of the Company16-05-2024
Sanofi India Results Earnings Call for Q1CY24
Conference Call with Sanofi India Management and Analysts on Q1CY24 Performance and Outlook. Listen to the full earnings transcript.16-05-2024
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s).16-05-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management
We wish to inform you that Dr. Shalini Menon, General Medicines Medical Head and India Medical Lead, has tendered her resignation from the Company to pursue other opportunities outside Sanofi.14-05-2024
Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 68th Annual General Meeting of the Company14-05-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of the Newspaper Publication of Financial Results for the quarter ended 31st March 202414-05-2024
Sanofi India Ltd - 500674 - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 31St March 2024
Unaudited standalone and consolidated financial results for the quarter ended 31st March 2024.13-05-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Directorate
We wish to inform you that the Board of Directors at its meeting held today i.e. Monday, 13th May 2024, based on the recommendation of the Nomination and Remuneration Committee, have approved the appointment of Mr. Eric Mansion as a Non-Executive Director of the Company with effect from 3rd June 2024, subject to the approval of the Members of the Company through Postal Ballot.13-05-2024
Sanofi India Ltd - 500674 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 31St March 2024
We refer to our letter dated 26th April 2024 informing you of our Board Meeting that was scheduled today. In this regard, we wish to inform you that the Board of Directors at its meeting held today i.e., Monday, 13th May 2024, inter-alia considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended 31st March 2024.13-05-2024